Imidazopyrazine tyrosine kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/4985 (2006.01) A61P 1/04 (2006.01) A61P 11/06 (2006.01) A61P 17/04 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2542481

Compounds of the formula (I) and pharmaceutically acceptable salts thereof, wherein Q1 and R1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of various diseases and conditions that respond to treatment by inhibition of tyrosine kinases.

L'invention concerne des composés de formule (I) et leurs sels pharmaceutiquement acceptables, formule dans laquelle Q?1 ¿et? ¿R?1¿ sont définis dans la description. Ces composés et ces sels inhibent l'enzyme IGF-1R et sont utiles pour le traitement et/ou la prévention de différentes maladies et états pathologiques qui réagissent à un traitement par inhibition des tyrosine kinases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazopyrazine tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazopyrazine tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyrazine tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1525071

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.